The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease
- 30 September 1994
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 88 (8) , 599-607
- https://doi.org/10.1016/s0954-6111(05)80008-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.Thorax, 1993
- TheophyllineDrug Safety, 1993
- Theophylline in the management of airflow obstruction. 2. Difficult drugs to use, few clinical indications.BMJ, 1990
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988
- 347 Comparison of oral, controlled-release albuterol (CR-A) and theophylline (T) in the treatment of chronic asthmaJournal of Allergy and Clinical Immunology, 1988
- Theophylline—How much is enough?Journal of Allergy and Clinical Immunology, 1986
- MULTICENTRE EVALUATION OF DISPOSABLE VISUAL MEASURING DEVICE TO ASSAY THEOPHYLLINE FROM CAPILLARY BLOOD SAMPLEThe Lancet, 1986
- THEOPHYLLINE PRESCRIBING, SERUM CONCENTRATIONS, AND TOXICITYThe Lancet, 1983
- Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adultsJournal of Pharmacokinetics and Biopharmaceutics, 1982
- The Comparison of Success Rates in Cross-Over Trials in the Presence of an Order EffectJournal of the Royal Statistical Society Series C: Applied Statistics, 1981